|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/37 | (2006.01) |
| A61K 38/37 | (2013.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61P 7/04 | (2018.01) |
| (11) | Patento numeris | 3641800 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18737505.0 |
| Europos patento paraiškos padavimo data | 2018-06-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-10-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2018/066696 |
| Data | 2018-06-22 |
| (87) | Numeris | WO 2018/234518 |
| Data | 2018-12-27 |
| (30) | Numeris | Data | Šalis |
| 17177477 | 2017-06-22 | EP | |
| 18153579 | 2018-01-26 | EP |
| (72) |
VERHAGEN, Anne , AU
PESTEL, Sabine , DE
WEIMER, Thomas , DE
HOFMANN, Marco , DE
HUYNH, Huy , AU
MARASKOVSKY, Eugene , AU
|
| (73) |
CSL Behring Lengnau AG ,
Biotech Innovation Park, 2543 Lengnau BE,
CH
|
| (54) | MODULATION OF FVIII IMMUNOGENICITY BY TRUNCATED VWF |
| MODULATION OF FVIII IMMUNOGENICITY BY TRUNCATED VWF |